Alice Li, PharmD

Articles by Alice Li, PharmD

Kateryna_Kon - stock.adobe.com

PARP inhibitors: Treating mCRPC from a genetic basis

ByAllen Jacob, MD,Jaret Shook,Thomas E. Hutson, PharmD, DO,Scott Webster, MD,Megan Price, MSN, APRN, FNP-C,Sujith Puskoor, DO,Antony Mathew, MD,Ammad Khan, MD,Alice Li, PharmD

December 18th 2020

Treatments provide a targeted therapeutic strategy for metastatic castration-resistant prostate cancer.

Latest Updated Articles

Trending on Urology Times

Trial launches of neuromodulation therapy for erectile dysfunction after radical prostatectomy

Andrea B. Apolo, MD, discusses survival gains with EV/pembrolizumab in bladder cancer

Rectal diazepam eases instillation of nadofaragene firadenovec in NMIBC

PROSTOX ultra launches on US market following new data presented at ASTRO 2025

Published data show benefit of niraparib with AAP in HRR-deficient mCSPC

© 2025 MJH Life Sciences^®

All rights reserved.